Motoko Y. Kimura

Chiba University — Japan

Immunology and Microbiology · Life Sciences

34h-index9.7kcitations125works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(61), T-cell and B-cell Immunology(42), Cancer Immunotherapy and Biomarkers(29), Immunotherapy and Immune Responses(21), CAR-T cell therapy research(16)

Publications125 total

Hepatic leukemia factor directs tissue residency of proinflammatory memory CD4 <sup>+</sup> T cells
Science·2025· 1 cited
Table S1 from CD69 Imposes Tumor-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell Fate in Tumor-Draining Lymph Nodes
2025Open Access
Table S3 from CD69 Imposes Tumor-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell Fate in Tumor-Draining Lymph Nodes
2025Open Access
Table S2 from CD69 Imposes Tumor-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell Fate in Tumor-Draining Lymph Nodes
2025Open Access
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 Imposes Tumor-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell Fate in Tumor-Draining Lymph Nodes
2025Open Access
Lipolysis-microlipophagy cascade regulated by adipose triglyceride lipase drives pathogenic adaptive type 2 immunity
Science Immunology·2025· 1 cited
CCL5 paradoxically regulates glomerular injury by skewing macrophage polarization
JCI Insight·2025Open Access
Anti-tumor effect of intratumoral administration of induced pluripotent stem cell-derived NKT cells on glioblastoma through CD155/DNAM-1 interaction
Stem Cells Translational Medicine·2025· 1 citedOpen Access
Differentiation of Cytotoxic CD8<sup>+</sup> T Cell Subsets Under Tumor Progression: Can CD69 Be a New Therapeutic Target?
Cancer Science·2025· 1 citedOpen Access
Table S2 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
2024Open Access
Table S3 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
2024Open Access
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
2024Open Access
Figure S1, S2, S3, S4, S5, S6, S7, S8, S9, S10, S11 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
2024Open Access
Table S3 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
2024Open Access
Table S1 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
2024Open Access
Table S2 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
2024Open Access
Table S1 from CD69 imposes tumor-specific CD8+ T-cell fate in tumor-draining lymph nodes
2024Open Access
Women in STEM becoming independent: Embrace failures as part of the journey to success
The Journal of Experimental Medicine·2024Open Access
Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients
Journal of Clinical Immunology·2024· 9 citedOpen Access
Exploring the Role of Platelets in Virus-Induced Inflammatory Demyelinating Disease and Myocarditis
International Journal of Molecular Sciences·2024· 4 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Toshinori Nakayama(42), Masakatsu Yamashita(28), Masaru Taniguchi(14), Akihiro Hasegawa(14), Hiroyuki Hosokawa(12), Chiori Shimizu(9), Alfred Singer(8), Haruhiko Koseki(7), Kiyoshi Hirahara(7), Shinichiro Motohashi(7), Terry I. Guinter(6), Masamichi Inami(6), Lionel Feigenbaum(5), Xuguang Tai(5), Ryo Shinnakasu(5), Kahoko Hashimoto(5), Ryo Koyama‐Nasu(5), Koji Tokoyoda(5), Chiaki Iwamura(5), Jung‐Hyun Park(4)